BIOCHEMISTRY OF TYPE XVI COLLAGEN
BIOCHEMISTRY OF TYPE XVI COLLAGEN
批准号:
2186007
负责人:
MON-LI H. CHU
金额:
$21.08万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-01-01 至 1996-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application proposes to study the biochemistry, molecular and
cellular biology of type XVI collagen, a novel collagen discovered by
cDNA cloning. the long term goal is to understand the biological role
of this new collagen. Recently cDNA clones encoding the entire human
alpha1(XVI) chain have been isolated and characterized. The overall
structural arrangement of the deduced polypeptide differs significantly
from other known collagen types. However, this polypeptide exhibits
certain structural features characteristically seen in members of the
fibril associated collagen, types IX, XII and XIV. It also resembles the
cuticle collagen of C. elegans in that both collagens contain similar
cysteine-rich motifs. In order to elucidate the biological function of
this collagen, we propose the following specific aims. (1) Preparation
and characterization of antibodies specific for the human alpha1(XVI)
collagen using synthetic peptides derived from the cDNA sequence and
recombinant proteins produced by expressing cDNA in cultured cells. (2)
Characterization of type XVI collagen in cultured cells and tissues. The
molecular size and chain composition of the native type XVI collagen will
be determined by immunoblotting and immunoprecipitation using antibodies
prepared above. (3) Elucidation of the spatial and temporal expression
of the alpha1(XVI) collagen. The mRNA and protein expression in cells
and tissues from humans and mice will be examined by RNA hybridization
and immunofluorescence staining. (4) Elucidation of the
structure/function relationship of the alpha1(VI) collagen using protein
fragments, synthetic peptides and recombinant proteins produced in the
mammalian expression system. (5) Characterization of other constituent
chain(s) of type XVI collagen if studies proposed above indicate that it
is a heterotrimer. (6) Isolation and characterization of the mouse
alpha1(XVI) collagen gene and use the genomic fragment to develop
transgenic mice with homozygous disruption of the alpha1(XVI) collagen
gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mouse Models for Elastic Fiber Diseases
-
批准号:7866691
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2009
-
负责人:MON-LI H. CHU
-
依托单位:
Mouse Models for Elastic Fiber Diseases
-
批准号:7740741
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2009
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7274779
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7125995
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7468046
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7022094
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7671459
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Zinc Finger Protein Zac1 and Chondrogenesis
-
批准号:6729826
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2003
-
负责人:MON-LI H. CHU
-
依托单位:
Zinc Finger Protein Zac1 and Chondrogenesis
-
批准号:6803601
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2003
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6299820
-
项目类别:
-
资助金额:$14.48万
-
财政年份:1999
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6100441
-
项目类别:
-
资助金额:$14.48万
-
财政年份:1998
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2701814
-
项目类别:
-
资助金额:$22.69万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6331026
-
项目类别:
-
资助金额:$29.56万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6607152
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6268356
-
项目类别:
-
资助金额:$14.09万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2024179
-
项目类别:
-
资助金额:$22.1万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2910304
-
项目类别:
-
资助金额:$23.36万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6757826
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6519806
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:6180694
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
骨胶原(Bio-Oss Collagen)联合龈下喷砂+骨皮质切开术治疗
根分叉病变的临床疗效研究
-
批准号:2024JJ9542
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:潘涛华
-
依托单位:
靶向A2BR/CollagenⅠ通路抑制循环肿瘤细胞团形成阻断肺癌转移的机制研究
-
批准号:82303467
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李青芳
-
依托单位:
HRD1通过调控自噬介导肺纤维化肌成纤维细胞collagen-Ⅰ高分泌的机制研究
-
批准号:82200080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘媛媛
-
依托单位:
Collagen VI 通过线粒体代谢/巨噬细胞调节机制调控CINP 的发生发展
-
批准号:2021JJ41060
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:朱小燕
-
依托单位:
基于Collagen/GPVI通路调控肿瘤基质屏障/凝血屏障增强anti-PD-1治疗乳腺癌药效及机制研究
-
批准号:82102917
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:朱运
-
依托单位:
肝星型细胞分泌 collagen I 激活盘状结构域受体DDR1-STAT3信号轴促进葡萄膜黑色素瘤肝转移的研究
-
批准号:82003797
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2020
-
负责人:戴伟
-
依托单位:
基于皮肤类器官模型探究TGFβ-Collagen-ROCK分子模块调控皮肤及其附属器官再生的机制
-
批准号:82003384
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:雷明星
-
依托单位:
四跨膜蛋白Tetraspanin 1结合Collagen I在特发性肺纤维化发病中的分子机制研究
-
批准号:82070061
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:刘刚
-
依托单位:
MGF-Notch/CollagenⅤ/CalcR-MSC:推拿增强骨骼肌重塑的新机制
-
批准号:81904318
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:丁海丽
-
依托单位:
CDX2/MMP1/Collagen-I正反馈通路介导的细胞外基质重构在结直肠癌侵袭转移中的作用机制研究
-
批准号:81972720
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:孙学军
-
依托单位: